NCT03896880COMPLETEDanonymous

Detection of Bloodstream Pathogens in Hematological Malignancies

Sponsor

Source record

Assiut University

Phase

Source record

Not classified

Modality

AI-normalized

gene therapy

Target

AI-normalized

blood culture, Anti fungal susceptibility testing or antibiotic susceptibility testing, phenotypic identification methods of the isolated organism by Vitek2 (BioMerieux,France), Identification of the isolated organism by multiplex PCR

Indication / condition

AI-normalized

Bloodstream Infection

Intervention

Source record

Related intelligence directories

Indication directory: Bloodstream Infection Modality directory: gene therapy Target directory: blood culture

Source & freshness

Source record

NCT ID

NCT03896880

Original source

ClinicalTrials.gov

Source last updated

May 16, 2023

Ingested at

Jun 19, 2026

Internal sync

Jun 19, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT03896880

Title

Detection of Bloodstream Pathogens in Hematological Malignancies

Sponsor

Assiut University

Status

COMPLETED

Phase

Detailed source ingestion pending

Condition raw

Bloodstream Infection

Condition normalized

Bloodstream Infection

Modality raw

gene therapy

Modality normalized

gene therapy

Target raw

Target normalized

Interventions

Public preview

Source record

To identify the common bacterial and fungal species causing fungemia and bacteremia in hematological malignancies.

To identify sensitivity pattern for causative microbes.

Compare culture on ordinary media with Vitek2 (automated microbial identification system) and multiplex polymerase chain reaction (PCR )

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Detection of Bloodstream Pathogens in Hematological Malignancies

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 19, 2026

NCT ID

NCT03896880

Status

COMPLETED

Phase

N/A

Sponsor

Assiut University

Executive brief

Investment-Ready Snapshot

* To identify the common bacterial and fungal species causing fungemia and bacteremia in hematological malignancies. * To identify sensitivity pattern for causative microbes. * Compare culture on ordinary media with Vitek2 (automated microbial identification system) and multiplex polymerase chain reaction (PCR )

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedMay 16, 2023

Internal syncJun 19, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03896880

Indication

Bloodstream Infection

Modality

gene therapy

Target

Intervention

Source record